StonvexLoading…
StonvexStonvexStonvexCore line items from CPBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|
Revenue | $24.70M | $20.96M | $16.14M |
Operating Income | $4.52M | $4.64M | $1.96M |
Net Income | $3.65M | $3.76M | $1.65M |
EPS (Diluted) | $0.96 | $2.19 | Not available |
Total Assets | $508.70M | $463.28M | $437.79M |
Total Liabilities | $425.37M | $385.00M | $399.13M |
Cash & Equivalents | $28.68M | $11.45M | $16.56M |
Free Cash Flow OCF − CapEx | $-3.07M | $3.43M | $4.17M |
Shares Outstanding | 4.21M | 4.13M | 0 |